| Product Code: ETC6966849 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Denmark Pharmacogenetic Testing Market Overview |
3.1 Denmark Country Macro Economic Indicators |
3.2 Denmark Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Denmark Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 Denmark Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 Denmark Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Denmark Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.7 Denmark Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Denmark Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.9 Denmark Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 Denmark Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 Denmark Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Denmark Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine |
4.2.2 Rising prevalence of chronic diseases in Denmark |
4.2.3 Government initiatives to promote precision medicine and genomics research |
4.3 Market Restraints |
4.3.1 High cost associated with pharmacogenetic testing |
4.3.2 Limited awareness among healthcare professionals and patients |
4.3.3 Regulatory challenges and reimbursement issues |
5 Denmark Pharmacogenetic Testing Market Trends |
6 Denmark Pharmacogenetic Testing Market, By Types |
6.1 Denmark Pharmacogenetic Testing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Denmark Pharmacogenetic Testing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Denmark Pharmacogenetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Denmark Pharmacogenetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 Denmark Pharmacogenetic Testing Market Revenues & Volume, By Array-Based Tests, 2021- 2031F |
6.1.6 Denmark Pharmacogenetic Testing Market Revenues & Volume, By Single Gene Tests, 2021- 2031F |
6.2 Denmark Pharmacogenetic Testing Market, By Gene Type |
6.2.1 Overview and Analysis |
6.2.2 Denmark Pharmacogenetic Testing Market Revenues & Volume, By CYP2C19, 2021- 2031F |
6.2.3 Denmark Pharmacogenetic Testing Market Revenues & Volume, By CYP2D6, 2021- 2031F |
6.2.4 Denmark Pharmacogenetic Testing Market Revenues & Volume, By CYP2C9 and VKORC1, 2021- 2031F |
6.2.5 Denmark Pharmacogenetic Testing Market Revenues & Volume, By CYP1A2, 2021- 2031F |
6.2.6 Denmark Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*1502, 2021- 2031F |
6.2.7 Denmark Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*5701, 2021- 2031F |
6.3 Denmark Pharmacogenetic Testing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Denmark Pharmacogenetic Testing Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.3.3 Denmark Pharmacogenetic Testing Market Revenues & Volume, By Nutraceuticals, 2021- 2031F |
6.3.4 Denmark Pharmacogenetic Testing Market Revenues & Volume, By Recreational Drugs, 2021- 2031F |
6.3.5 Denmark Pharmacogenetic Testing Market Revenues & Volume, By Herbal Supplements, 2021- 2031F |
6.3.6 Denmark Pharmacogenetic Testing Market Revenues & Volume, By Vitamins, 2021- 2031F |
6.3.7 Denmark Pharmacogenetic Testing Market Revenues & Volume, By Over-the-Counter Medications, 2021- 2031F |
6.4 Denmark Pharmacogenetic Testing Market, By Sample |
6.4.1 Overview and Analysis |
6.4.2 Denmark Pharmacogenetic Testing Market Revenues & Volume, By Blood, 2021- 2031F |
6.4.3 Denmark Pharmacogenetic Testing Market Revenues & Volume, By Saliva, 2021- 2031F |
6.5 Denmark Pharmacogenetic Testing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 Denmark Pharmacogenetic Testing Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.5.3 Denmark Pharmacogenetic Testing Market Revenues & Volume, By Gastroenterology, 2021- 2031F |
6.5.4 Denmark Pharmacogenetic Testing Market Revenues & Volume, By Anesthesiology, 2021- 2031F |
6.5.5 Denmark Pharmacogenetic Testing Market Revenues & Volume, By Genomics, 2021- 2031F |
6.5.6 Denmark Pharmacogenetic Testing Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.5.7 Denmark Pharmacogenetic Testing Market Revenues & Volume, By Immunology & Hypersensitivity, 2021- 2031F |
6.5.8 Denmark Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 Denmark Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Denmark Pharmacogenetic Testing Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 Denmark Pharmacogenetic Testing Market Revenues & Volume, By Clinical Practice, 2021- 2031F |
6.6.3 Denmark Pharmacogenetic Testing Market Revenues & Volume, By Drug Development, 2021- 2031F |
6.6.4 Denmark Pharmacogenetic Testing Market Revenues & Volume, By Drug Regulation, 2021- 2031F |
6.7 Denmark Pharmacogenetic Testing Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Denmark Pharmacogenetic Testing Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.7.3 Denmark Pharmacogenetic Testing Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.7.4 Denmark Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Denmark Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 Denmark Pharmacogenetic Testing Market Import-Export Trade Statistics |
7.1 Denmark Pharmacogenetic Testing Market Export to Major Countries |
7.2 Denmark Pharmacogenetic Testing Market Imports from Major Countries |
8 Denmark Pharmacogenetic Testing Market Key Performance Indicators |
8.1 Adoption rate of pharmacogenetic testing by healthcare providers |
8.2 Number of research studies and clinical trials involving pharmacogenetics in Denmark |
8.3 Rate of development and commercialization of new pharmacogenetic tests |
9 Denmark Pharmacogenetic Testing Market - Opportunity Assessment |
9.1 Denmark Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Denmark Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
9.3 Denmark Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Denmark Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.5 Denmark Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 Denmark Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 Denmark Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Denmark Pharmacogenetic Testing Market - Competitive Landscape |
10.1 Denmark Pharmacogenetic Testing Market Revenue Share, By Companies, 2024 |
10.2 Denmark Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here